Usefulness of Polygenic Risk Score for Intraventricular Septal Diameter in Patients With Hypertrophic Cardiomyopathy

被引:0
|
作者
Nomura, Akihiro
Sato, Takehiro
Noguchi, Masahiro
Takeji, Yasuaki
Tada, Hayato
Hayashi, Kenshi
Tajima, Atsushi
Takamura, Masayuki
Fujino, Noboru
机构
关键词
Hypertrophic cardiomyopathy; Polygenic Risk;
D O I
10.1161/circ.148.suppl_1.17207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A17207
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction
    Desai, Milind Y.
    Owens, Anjali
    Wolski, Kathy
    Geske, Jeffrey B.
    Saberi, Sara
    Wang, Andrew
    Sherrid, Mark
    Cremer, Paul C.
    Lakdawala, Neal K.
    Tower-Rader, Albree
    Fermin, David
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Zhong, Yue
    Wyrwich, Kathleen W.
    Lampl, Kathy L.
    Sehnert, Amy J.
    Nissen, Steven E.
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (11) : 1041 - 1045
  • [32] Mavacamten, an Alternative to Septal Reduction Therapy for Patients with Hypertrophic Cardiomyopathy
    Desai, Milind Y.
    Ali, Adel Hajj
    HEART INTERNATIONAL, 2023, 17 (01): : 2 - 4
  • [33] Impact of Septal Curvature on Regional Strain in Patients With Hypertrophic Cardiomyopathy
    Inoue, Katsuji
    Okayama, Hideki
    Nishimura, Kazuhisa
    Nagai, Takayuki
    Suzuki, Jun
    Ogimoto, Akiyoshi
    Saito, Makoto
    Yoshii, Toyofumi
    Hiasa, Go
    Sumimoto, Takumi
    Funada, Jun-ichi
    Shigematsu, Yuji
    Hamada, Mareomi
    Higaki, Jitsuo
    CIRCULATION JOURNAL, 2013, 77 (04) : 1040 - 1045
  • [34] Risk stratification in patients with hypertrophic cardiomyopathy
    Elliott, PM
    McKenna, WJ
    CARDIAC ARRHYTHMIAS, PACING & ELECTROPHYSIOLOGY: THE EXPERT VIEW, 1998, 201 : 83 - 88
  • [35] Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy
    Seggewiss H.
    Current Cardiology Reports, 2001, 3 (2) : 160 - 166
  • [36] ATRIAL FIBRILLATION POLYGENIC RISK SCORE IS CORRELATED WITH THE INCIDENCE OF NONISCHEMIC CARDIOMYOPATHY
    Fohle, Emmanuel
    Nadkarni, Ninad
    Naseer, Usman
    Stys, Patryk
    Weaver, Max
    Stys, Krystina
    Rotter, Jerome
    Merrill, Luke
    Yu, Ethan
    Guo, Xiuqing
    Larson, Eric
    Hajek, Catherine
    Bartaria, Shubhi
    Gu, Shaopeng
    Rajpurohit, Naveen
    Petrasko, Marian S.
    Stys, Adam T.
    Stys, Tomasz P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 124 - 124
  • [37] Predictors of Repeated Septal Reduction After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy
    Hiruma, Takashi
    Kitamura, Mitsunobu
    Takamisawa, Itaru
    Izumi, Yuki
    Higuchi, Ryosuke
    Nanasato, Mamoru
    Shimokawa, Tomoki
    Takanashi, Shuichiro
    Isobe, Mitsuaki
    Takayama, Morimasa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (04)
  • [38] A practical score for risk stratification of embolic stroke in hypertrophic cardiomyopathy
    Benchimol Barbosa, P. R.
    Barbosa, E. C.
    Bomfim, A. S.
    Ribeiro, R. L.
    Boghossian, S. H.
    Kantharia, B. K.
    EUROPEAN HEART JOURNAL, 2013, 34 : 531 - 531
  • [39] Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy
    Cui, Hao
    Schaff, Hartzell, V
    Wang, Shuiyun
    Lahr, Brian D.
    Rowin, Ethan J.
    Rastegar, Hassan
    Hu, Shengshou
    Eleid, Mackram F.
    Dearani, Joseph A.
    Kimmelstiel, Carey
    Maron, Barry J.
    Nishimura, Rick A.
    Ommen, Steve R.
    Maron, Martin S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (17) : 1647 - 1655
  • [40] Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
    Rowin, Ethan J.
    Cooper, Craig
    Carrick, Richard T.
    Tsoi, Melissa
    Maron, Barry J.
    Maron, Martin S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 179 : 70 - 73